Director W. Thorpe McKenzie retires from XBiotech board effective March 27, 2025

XBiotech Inc.

McKenzie served since 2009; was on Audit, Compensation, and Nominating Committees.
Retirement not due to any dispute or disagreement with the company.
Audit Committee reduced to one member (Jan-Paul Waldin); vacancies to be filled per NASDAQ rules.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

W. Thorpe McKenzie

Director

XBIT · XBiotech Inc.

Effective: 2025-03-27
Filed: April 1, 2025, 7:59 PM ET

On March 27, 2025, W. Thorpe McKenzie informed the Board of Directors (the “Board”) of XBiotech Inc. (the “Company”) via letter of his decision to retire from the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

W. Thorpe McKenzie retired as Director at XBiotech Inc..

Action: retired
Role: Director

Exact text from the filing

On March 27, 2025, W. Thorpe McKenzie informed the Board of Directors (the “Board”) of XBiotech Inc. (the “Company”) via letter of his decision to retire from the Board, effective immediately.

View on SEC.gov

XBiotech Inc. filing history →

Source: SEC EDGAR

accession 0001171843-25-001876

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.